Loading...
Symbols:
Loading...
Symbols:
Gilead Sciences Inc. (GILD)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Gilead Sciences Inc. (GILD)
108 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on GILD
- SA Editor Miriam Metzinger(33)
- SA Editors(13)
- Centient Biotech Investor(10)
- SA Editor Eli Hoffmann(7)
- BioBlogger (6)
Most popular authors
(tracked in watchlists)
- Bespoke Investment Group(537)
- Trader Mark(459)
- SA Editor Eli Hoffmann(379)
- Roger Nusbaum(309)
- Andrew Wilkinson(304)
Most commented on authors
- SA Editor Eli Hoffmann(31)
- SA Editor Miriam Metzinger(28)
- Ohad Hammer(14)
- Trader Mark(11)
- Option Dragon(10)
- Hedge Fund Tracking: Lee Ainslie's Maverick Capital, Q3 2008
- 5 Health Care Stocks for Value Investors
- Rigel Pharmaceuticals: Biotech Crisis or Opportunity?
- Recessionary Equity Strategies: Still Going for Growth
- Best Performing S&P 500 Stocks During the Bush Years
- Recessionary Equity Strategies: Flight to Quality
- Expanding the Defensive Growth Index Into Europe
- J.P. Morgan's 16 Picks in Troubled Times
- Gilead Turns in Sweet Earnings Numbers
- Wall Street Breakfast: Must-Know News
- Earnings on Tap for Thursday, Fingers Crossed
- Some Good News in Biotech
- 'When There's Blood in the Streets', Buy Biotech Stocks
- Hedge Fund Tracking: Caxton Associates (Bruce Kovner)
- Three Biotech ETFs: A Way To Follow the 'Smart Money' into Healthcare
- Board and Executive Compensation in S&P 500
- S&P 500's Best and Worst Net Income Change
- Time for Biotech? - Fast Money Recap (07/29/08)
- Biotech Bucks the Market Trend
- A Biotech Bloom in July
- Roche's Genentech Offer Sends Ripples Through Biotech
- Five Strategies to Survive the Markets
- Gilead Sciences: Industry Landscape, Strong Growth Make It a Buy
- Friday Options Update: MSFT, BAC, MIR, OSTK, GILD, BRL, MAT
- Healthcare 'Safe'? Nobody Told Gilead
- Wall Street Breakfast: Must-Know News
- Welcome to Massive-Earnings Thursday
- Big Biotech Booms But IBB Falls Flat
- Do Tell, Intel - Fast Money Recap (7/15/08)
- In Tech We Trust - Fast Money Recap (6/20/08)
- Will M&A Activity Boost PowerShares Dynamic Biotech & Genome ETF?
- Fixing Pfizer
- Much Ado about Yahoo, Fast Money Recap, (4/21/08)
- Gilead Sciences 'Pushes Out' Amgen As Number 2 Biotech
- Under The Radar News - Thursday
- Pfizer Should Buy Amgen or Wyeth - Credit Suisse
- Under The Radar News - Monday
- Gold's Just Getting Started - Barron's Interview
- Gilead Keeps Going Strong
- Baby Boomers: Invest with the Trend
- Staying Away From Retail, Gadgets
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »